{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:30:22Z","timestamp":1791199822901,"version":"4.2.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:00:00Z","timestamp":1680393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jsps.2023.04.002","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T06:31:31Z","timestamp":1681194691000},"page":"795-800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC\/AHA guidelines"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3849-9372","authenticated-orcid":false,"given":"Amro","family":"Matyori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clyde P.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0535-6300","authenticated-orcid":false,"given":"Askal","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1597-3967","authenticated-orcid":false,"given":"Fatimah","family":"Sherbeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2023.04.002_b0005","unstructured":"Agency for Healthcare Research and Quality, 2019, April. The Medical Expenditure Panel Survey."},{"issue":"10","key":"10.1016\/j.jsps.2023.04.002_b0010","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1161\/CIRCULATIONAHA.105.548198","article-title":"Revised adult treatment panel III guidelines and cardiovascular disease mortality in men attending a preventive medical clinic","volume":"112","author":"Ardern","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jsps.2023.04.002_b0015","unstructured":"Centers for Disease Control and Prevention, 2020, June. International Classification of Diseases Codes."},{"issue":"1","key":"10.1016\/j.jsps.2023.04.002_b0020","first-page":"13","article-title":"Current and emerging uses of statins in clinical therapeutics: a review","volume":"9","author":"Davies","year":"2016","journal-title":"Lipid Insights"},{"issue":"8","key":"10.1016\/j.jsps.2023.04.002_b0025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003558","article-title":"2013 ACC\/AHA cholesterol guideline and implications for healthy people 2020 cardiovascular disease prevention goals","volume":"5","author":"Egan","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.jsps.2023.04.002_b0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10557-018-6810-1","article-title":"Trends in Statin Use 2009\u20132015 in a large integrated health system: pre- and post-2013 ACC\/AHA guideline on treatment of blood cholesterol","volume":"32","author":"Harrison","year":"2018","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"9","key":"10.1016\/j.jsps.2023.04.002_b0035","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jamainternmed.2016.3384","article-title":"Effect of generic competition on atorvastatin prescribing and patients\u2019 out-of-pocket spending","volume":"176","author":"Luo","year":"2016","journal-title":"JAMA Internal Medicine"},{"issue":"6","key":"10.1016\/j.jsps.2023.04.002_b0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3122\/jabfm.2019.06.180313","article-title":"Statin Use in the U.S. For secondary prevention of cardiovascular disease remains suboptimal","volume":"32","author":"Ngo-Metzger","year":"2019","journal-title":"J. Am. Board Family Medicine"},{"issue":"3","key":"10.1016\/j.jsps.2023.04.002_b0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004909","article-title":"Effect of 2013 ACC\/AHA blood cholesterol guidelines on statin treatment patterns and low-density lipoprotein cholesterol in atherosclerotic cardiovascular disease patients","volume":"6","author":"Okerson","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"20","key":"10.1016\/j.jsps.2023.04.002_b0050","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2019.09.026","article-title":"Trends in lipid, lipoproteins, and statin use among U.S. adults: impact of 2013 cholesterol guidelines","volume":"74","author":"Patel","year":"2019","journal-title":"J. Am. College Cardiol."},{"issue":"2","key":"10.1016\/j.jsps.2023.04.002_b0055","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jvs.2014.06.100","article-title":"Application of new cholesterol guidelines to a population-based sample","volume":"60","author":"Pencina","year":"2014","journal-title":"J. Vascular Surg."},{"issue":"4","key":"10.1016\/j.jsps.2023.04.002_b0060","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamacardio.2016.5922","article-title":"Adoption of the 2013 American College of Cardiology\/American Heart Association cholesterol management guideline in cardiology practices nationwide","volume":"2","author":"Pokharel","year":"2017","journal-title":"JAMA Cardiol."},{"issue":"1","key":"10.1016\/j.jsps.2023.04.002_b0065","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.atherosclerosis.2014.09.023","article-title":"The 2013 ACC\/AHA cardiovascular prevention guidelines improve alignment of statin therapy with coronary atherosclerosis as detected by coronary computed tomography angiography","volume":"237","author":"Pursnani","year":"2014","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.jsps.2023.04.002_b0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jacc.2014.09.088","article-title":"Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease","volume":"65","author":"Rosenson","year":"2015","journal-title":"J. Am. College Cardiol."},{"issue":"25","key":"10.1016\/j.jsps.2023.04.002_b0080","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. College Cardiol."},{"issue":"1","key":"10.1016\/j.jsps.2023.04.002_b0085","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamacardio.2016.4700","article-title":"National trends in statin use and expenditures in the U.S. adult population from 2002 to 2013: insights from the Medical Expenditure Panel Survey","volume":"2","author":"Salami","year":"2017","journal-title":"JAMA Cardiol."},{"issue":"6","key":"10.1016\/j.jsps.2023.04.002_b0090","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/clc.23347","article-title":"Trends in prevalence of guideline-based use of lipid-lowering therapy in a large health system","volume":"43","author":"Sidebottom","year":"2020","journal-title":"Clin. Cardiol."},{"issue":"12","key":"10.1016\/j.jsps.2023.04.002_b0095","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4065\/mcp.2009.0298","article-title":"Cardiovascular and economic outcomes after initiation of lipid-lowering therapy with atorvastatin vs simvastatin in an employed population","volume":"84","author":"Simpson","year":"2009","journal-title":"Mayo Clinic Proc."},{"key":"10.1016\/j.jsps.2023.04.002_b0100","doi-asserted-by":"crossref","unstructured":"Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., McBride, P., Schwartz, J. S., Shero, S. T., Smith, S. C., Watson, K., & Wilson, P. W. F., 2014. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the american college of cardiology\/american heart association task force on practice guidelines. In: Circulation (Vol. 129, Issue 25 SUPPL. 1). Lippincott Williams and Wilkins. https:\/\/doi.org\/10.1161\/01.cir.0000437738.63853.7a.","DOI":"10.1161\/01.cir.0000437738.63853.7a"},{"key":"10.1016\/j.jsps.2023.04.002_b0105","unstructured":"Tolbert, J., 2022, The Coverage Provisions in the Affordable Care Act: An Update. Health Insurance Market Reforms."},{"key":"10.1016\/j.jsps.2023.04.002_b0110","unstructured":"U.S. Bureau of Labor Statistics. (2021, January). Consumer Price Index."},{"key":"10.1016\/j.jsps.2023.04.002_b0115","doi-asserted-by":"crossref","unstructured":"Warraich, H. J., Salami, J. A., Khera, R., Valero-Elizondo, J., Okunrintemi, V., & Nasir, K. (2018). Trends in use and expenditures of brand-name atorvastatin after introduction of generic atorvastatin. In: JAMA Internal Medicine (Vol. 178, Issue 5). American Medical Association, pp. 719\u2013721. https:\/\/doi.org\/10.1001\/jamainternmed.2018.0990.","DOI":"10.1001\/jamainternmed.2018.0990"},{"key":"10.1016\/j.jsps.2023.04.002_b9000","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1155\/2020\/3987065","article-title":"Comparative Lipid-Lowering\/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials","volume":"2020","author":"Zhang","year":"2020","journal-title":"Cardiovascular therapeutics"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:30:20Z","timestamp":1736184620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016423000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1319016423000841"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2023.04.002","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC\/AHA guidelines","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2023.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}